Publication | Closed Access

Asymmetric Dimethyl-l-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease

HypertensionHeart FailurePulmonary Arterial HypertensionCardiovascular DiseasePulmonary HypertensionAdult Congenital Heart DiseaseCongenital Heart DefectAsymmetric Dimethyl-l-argininePublic HealthCongenital Heart AnomalyMedicineCardiologyCardiovascular GeneticsPulmonary Vascular DiseasePulmonary Hypertension AssociatedCongenital Heart Disease